Motor function measure scale: Portuguese version and reliability analysis

Revista Brasileira de Fisioterapia

Volumn 12, Issue 5, 2008, Pages 417-424

  Iwabe, Cristina ^a   Miranda Pfeilsticker, B H ^a   Nucci, A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Motor activity; Neuromuscular disorders; Reliability study; Scales

Indexed keywords

EID: 58149193303     PISSN: 14133555     EISSN: 18099246     Source Type: Journal    
DOI: 10.1590/s1413-35552008000500012     Document Type: Article

References (28)

1. Vasta I, Kinali M, Messina S, Guzzetta A, Kapellou O, Manzur A et al. Can clinical signs identify newborns with neuromuscular disorders? J Pediatr. 2005;146(1):73-9.
2. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. 1. The design of the protocol. Muscle Nerve. 1981;4(3):186-97.
3. Cutter NC, Kevorkian CG. Provas funcionais musculares. São Paulo: Manole; 2000.
4. Bérard C, Payan C, Hodgkinson I, Fermanian J. The MFM Collaborative Study Group. A motor function measure scale for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 2005;15(7): 463-70.
5. Bérard C, Payan C, Fermanian J, Girardot F, Groupe d'Etude MFM. A motor function measurement scale for neuromuscular disease - description and validation study. Rev Neurol (Paris). 2006;162(4):485-93.
6. Amiel-Tison C, Grenier A. Evaluation neurologique du nouveau-ne et du nouresson. Paris: Masson; 1980.
7. Richer LP, Shevell MI, Miller SP. Diagnostic profile of neonatal hypotonia: an 11-year study. Pediatr Neurol. 2001;25(1):32-7.
8. Medical Research Council. Aids to the examination of the peripheral nervous system. London: HMSO; 1976.
9. Lue YJ, Su CY, Yang RC, Su WL, Lu YM, Lin RF et al. Development and validation of muscular dystrophy - specific functional rating scale. Clin Rehabil. 2006;20(9):804-17.
10. Jensen MP, Abresch RT, Carter GT. The reliability and validity of a self report version of the FIM instrument in persons with neuromuscular disease and chronic pain. Arch Phys Med Rehabil. 2005;86(1):116-22.
11. Scott E, Mawson SJ. Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool. Dev Med Child Neurol. 2006;48(6):540-4.
12. Vicent KA, Carr AJ, Walburn J, Scott DL, Rose MR. Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology. 2007;68(13):1051-7.
13. Russman BS, Buncher CR, White M, Samaha FJ, Iannaccone ST. Function changes in spinal muscular atrophy II and III. The DCN/SMA Group. Neurology. 1996;47(4):973-6.
14. Main M, Kairon H, Mercuri E, Muntoni F. The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol. 2003;7(4):155-9.
15. Merlini L, Bertini E, Minetti C, Mongini T, Morandi L, Angelini C et al. Motor function-muscle strength relationship in spinal muscular atrophy. Muscle Nerve. 2004;29(4):548-52.
16. Lord JP, Portwood MM, Fowler WM, Lieberman JS, Carson R. Upper vs lower extremity functional loss in neuromuscular disease. Arch Phys Med Rehabil. 1987;68(1):8-9.
17. Vignos PJ, Spencer GE, Archibald KC. Management of progressive muscular dystrophy of childhood. JAMA. 1963;184:89-96.
18. Werneck LC. Correlation between functional disability, age and serum enzymes in neuromuscular diseases. Arq Neuropsiquiatr. 1995;53(1):60-8.
19. Rocco FM, Luz FHG, Rossato AJ, Fernandes AC, Oliveira ASB, Beteta JT et al. Avaliação da função motora em crianças com distrofia muscular congênita com deficiência da merosina. Arq Neuropsiquiatr. 2005;63(2):298-306.
20. Durigon OFS, Sá CSS, Sitta LV. Validação de um protocolo de avaliação do tono muscular e atividades funcionais para crianças com paralisia cerebral. Revista Neurociências. 2004;12(2):87-93.
21. Maki T, Quagliato EMAB, Cacho EWA, Paz LPS, Nascimento NH, Inoue MMEA, et al. Estudo da confiabilidade da aplicação da escala de Fugl- Meyer no Brasil. Rev Bras Fisioter. 2006;10(2):177-83.
22. Martinez JAB, Brunherotti MA, Assis MR, Sobreira CFR. Validação da escala motora funcional EK para a língua portuguesa. Rev Assoc Med Bras. 2006;52(5):347-51.
23. Cicconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol. 1999;39(3):143-50.
24. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417-32.
25. Vartanian JG, Carvalho AL, Yueh B, Furia CL, Toyota J, McDowell EA Jr et al. Brazilian-Portuguese validation of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer. Head Neck. 2006;28(12):1115-21.
26. Carthery-Goulart MT, Areza-Fegyveres R, Schultz RR, Okamoto I, Caramelli P, Bertlucci PHF et al. Adaptação transcultural da escala de avaliação de incapacidade em demência (disability assessment for dementia - DAD). Arq Neuropsiquiatr. 2007;65(3-B):916-9.
27. Van den Beld WA, Van der Sanden GAC, Sengers RCA, Verbeek ALM, Gabreels FJM. Validity and reproducibility of a new diagnostic motor performance test in children with suspected myopathy. Dev Med Child Neurol. 2006;48(1):20-7.
28. Gladstone DJ, Daniells CJ, Black SE. The fugl-meyer assessment of motor recovery after stroke: a critical review of its measurement properties. Neurorehabil Neural Repair. 2002;16(3):232-40.